MedPath

Role of dexamethasone as an additive agent in erector spinae block for pain relief in patients undergoing back pain surgery: A randomized clinical trial

Phase 4
Recruiting
Conditions
Other spondylosis,
Registration Number
CTRI/2020/06/025661
Lead Sponsor
department of anesthesia AIIMS BBSR
Brief Summary

ERECTOR SPINAE BLOCK HAS BEEN RECENTLY FOUND TO BE USEFUL FOR POST OPERATIVE PAIN MANGEMENT IN SPINE SURGERY PATIENST. THROUGH THIS STUDY WE PLAN TO EVELAUTE THE ROLE OF DEXAMETHASONE AS AN ADUVANT IN SPINE SURGERY

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
50
Inclusion Criteria

Patients age: 18-65 years, American Society of Anesthesiologists 1 or 2 classifications undergoing single or two levels lumbar/ thoracic diskectomy surgery will be enrolled under this study.

Exclusion Criteria
  • 1)Refusal to consent 2)Infection at the infiltration site 3)Any history of allergy to local anesthetics 4)Failed back surgery syndromes 5)History of chronic pain, narcotic abuse or alcohol dependence.
  • 6)Opioid use in the last 24 hours before surgery.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome :POST OPERATIVE
Time to first rescue analgesia or time at which first rescue analgesia was provided based on VAS ≥4POST OPERATIVE
Secondary Outcome Measures
NameTimeMethod
Visual analogue score at 1hr, 2hr, 4hr, 6hr and 24h after surgery at rest and movement, incidence of post- operative nausea vomiting and time required for mobilisation will be compared between the two groups.POST OPERATIVE

Trial Locations

Locations (1)

AIIMS, BHUBANESWAR

🇮🇳

Khordha, ORISSA, India

AIIMS, BHUBANESWAR
🇮🇳Khordha, ORISSA, India
NITASHA MISHRA
Principal investigator
8373938016
nitsmishra@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.